Intellia Therapeutics Head office building


Bill Chase

Bill Chase is a financial and business executive with more than three decades of strategic and financial management experience at leading life science companies. In addition to serving on Intellia’s board and as a member of the audit committee, he also serves on the board of Parexel International.

Previously, Bill served as executive vice president and chief financial officer of AbbVie, following the company’s successful spinout from Abbott Laboratories, in 2012 until 2018. He then went on to serve as executive vice president, Finance and Administration, from October 2018 to July 2019.

Prior to his tenure at AbbVie, Bill spent nearly 25 years in financial management positions of increasing seniority at Abbott, including corporate vice president, Licensing & Acquisitions; corporate vice president and treasurer; and divisional vice president and controller of Abbott International.

Bill holds a bachelor’s degree in finance from the University of Illinois and an MBA from the University of Chicago Booth School of Business.
Financial Expert
Independent Director